Stockscreener 앱 받기
1.15
0.00%
0.00
전일 마감가:
$1.15
열려 있는:
$1.15
하루 거래량:
190.83K
Relative Volume:
0.81
시가총액:
$99.17M
수익:
-
순이익/손실:
$-27.09M
주가수익비율:
-2.8494
EPS:
-0.4036
순현금흐름:
$-26.52M
1주 성능:
+1.77%
1개월 성능:
+0.88%
6개월 성능:
-16.67%
1년 성능:
+0.00%
1일 변동 폭
$1.15
$1.1789
1주일 범위
$1.10
$1.24
52주 변동 폭
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
명칭
Vivani Medical Inc
전화
415-506-8462
주소
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.15 | 99.17M | 0 | -27.09M | -26.52M | -0.4036 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vivani Medical Inc (VANI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Vivani Medical Inc (VANI) Institutional Confidence - TradingKey
Vivani Medical Inc (VANI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vivani Medical Inc (VANI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Insider Stock Purchases: June 16, 2026 - Quiver Quantitative
Vivani Medical director Gregg Williams purchases $2 million common stock - Investing.com
Vivani Medical Insider Bought Shares Worth $1,999,999, According to a Recent SEC Filing - marketscreener.com
Vivani Medical Inc (VANI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VANI Q1 2026 Earnings: Narrowed Loss Beat Estimates, Stock Slips Despite ProgressAnalyst Earnings Estimate - newsline.com
VANI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock DeclineEBITDA Margin Trends - newsline.com
Vivani Medical (VANI) Holds Near Support After Slight DeclineForce Index - newsline.com
VANI Q1 2026 Earnings: Narrower-than-expected loss highlights clinical progress in obesity pipelineRevenue Beat Analysis - newsline.com
VANI Stock Price, Quote & Chart - ChartMill
Vivani Medical (VANI) Slips 2.54% as Stock Tests Key Support at $1.09Aggressive Growth Picks - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss and Pipeline Progress Amidst Stock DeclineProduct Revenue Analysis - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Preparations Continue - newsline.com
VANI News | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill
Vivani Medical Highlights Investor Presentation at Jefferies Conference - TipRanks
Vivani to Present CEO Slide Deck at Jefferies Global Healthcare Conference - TradingView
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 - markets.businessinsider.com
VANI Q1 2026 Earnings: Narrower Than Expected Loss Drives Positive Stock ReactionPost-Earnings Drift - newsline.com
Vivani Medical Q1 2026 Earnings: Slight EPS Beat Signals Progress Despite No RevenueUpward Estimate Revision - The Legal Advocate
Vivani Medical Q1 2026 Earnings: Narrower Net Loss Surpasses ExpectationsMargin Compression Risk - Newser
Vivani Medical (VANI) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionProfit Announcement - newsline.com
Vivani Medical Q1 2026 Earnings: Slight EPS Beat Fails to Stem Stock Decline as Pre-Revenue Biotech Navigates Development PipelineExpert Trade Signals - Newser
Vivani Medical director Gregg Williams buys $2m in common stock - Investing.com
Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation - Yahoo Finance
Vivani Medical (VANI) price target increased by 10.00% to 5.61 - MSN
Vivani Medical 1Q Loss/Shr 8c >VANI - Moomoo
Vivani Medical 1Q Loss $6.78M >VANI - Moomoo
Vivani Highlights Q1 Progress on Semaglutide Implant Program - TipRanks
Vivani Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Vivani Medical, Inc. 1Q 2026: Net income $(6.78M), EPS $(0.08) — 10-Q Summary - TradingView
Vivani Medical: Q1 Earnings Snapshot - marketscreener.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - marketscreener.com
TradingKey - TradingKey
Vivani Medical Insider Ups Holding By 17% During Year - simplywall.st
Number of shareholders of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday - MarketBeat
VANI Fundamental Analysis & Valuation | Fair Value & Financial Strength | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill
Vivani (VANI) Stock: Is It Worth Allocating Capital | Q4 2025: Better Than ExpectedExpert Breakout Alerts - newser.com
Vivani Medical Inc (VANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.44%
자본화:
|
볼륨(24시간):